Correlation Between Heart Test and NLS Pharmaceutics

Can any of the company-specific risk be diversified away by investing in both Heart Test and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Heart Test and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Heart Test Laboratories and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Heart Test and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Heart Test with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Heart Test and NLS Pharmaceutics.

Diversification Opportunities for Heart Test and NLS Pharmaceutics

-0.31

Correlation Coefficient

Heart Test  NLS Pharmaceutics

Very good diversification

The 3 months correlation between Heart and NLS is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Heart Test Laboratories and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Heart Test is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Heart Test Laboratories are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Heart Test i.e., Heart Test and NLS Pharmaceutics go up and down completely randomly.

Pair Corralation between Heart Test and NLS Pharmaceutics

Assuming the 90 days horizon Heart Test Laboratories is expected to generate 0.85 times more return on investment than NLS Pharmaceutics. However, Heart Test Laboratories is 1.17 times less risky than NLS Pharmaceutics. It trades about 0.17 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about 0.08 per unit of risk. If you would invest  3.50  in Heart Test Laboratories on December 19, 2024 and sell it today you would earn a total of  1.47  from holding Heart Test Laboratories or generate 42.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	32.2%
Values	Daily Returns

Heart Test Laboratories  vs.  NLS Pharmaceutics AG

Heart Test Laboratories

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Heart Test Laboratories are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Heart Test showed solid returns over the last few months and may actually be approaching a breakup point.

NLS Pharmaceutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NLS Pharmaceutics AG are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, NLS Pharmaceutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Heart Test and NLS Pharmaceutics

The main advantage of trading using opposite Heart Test and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Heart Test position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.

The idea behind Heart Test Laboratories and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.